Evidence map›Paper›PMID 37849926›Full record

ArticleFrontiers in microbiology2023

Application of the endogenous CRISPR-Cas type I-D system for genetic engineering in the thermoacidophilic archaeon

Jan Bost, Alejandra Recalde, Bianca Waßmer, Alexander Wagner, Bettina Siebers, Sonja-Verena Albers

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Journal of bacteriology · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. CRISPR/Cas system and its application in the diagnosis of animal infectious diseases.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jan BostMolecular Biology of Archaea, Microbiology, Faculty of Biology, University of Freiburg, Freiburg, Germany.
Alejandra RecaldeMolecular Biology of Archaea, Microbiology, Faculty of Biology, University of Freiburg, Freiburg, Germany.
Bianca WaßmerMolecular Biology of Archaea, Microbiology, Faculty of Biology, University of Freiburg, Freiburg, Germany.
Alexander WagnerMolecular Enzyme Technology and Biochemistry (MEB), Environmental Microbiology and Biotechnology (EMB), Centre for Water and Environmental Research (CWE), Faculty of Chemistry, University of Duisburg-Essen, Essen, Germany.
Bettina SiebersMolecular Enzyme Technology and Biochemistry (MEB), Environmental Microbiology and Biotechnology (EMB), Centre for Water and Environmental Research (CWE), Faculty of Chemistry, University of Duisburg-Essen, Essen, Germany.
Sonja-Verena AlbersMolecular Biology of Archaea, Microbiology, Faculty of Biology, University of Freiburg, Freiburg, Germany.
University of Freiburg · DEUniversity of Duisburg-Essen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CRISPR (clustered regularly interspaced short palindromic repeats)-Cas systems are widely distributed among bacteria and archaea. In this study, we demonstrate the successful utilization of the type I-D CRISPR-Cas system for genetic engineering in the thermoacidophilic archaeon

Indexed as

archaeadeletion mutantgenetic engineeringgenetic toolsprotospacer adjacent motiftype I-D CRISPR system

Identifiers

PMID37849926
PMCPMC10577407
OpenAlexW4387305114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.